NMTI looks good here--in at 14.44

Discussion in 'Trading' started by hitman4gk, Mar 1, 2007.

  1. NMT Medical-NMTI could be an acquisition target within next 12-24 months@CIBC
    CIBC said the FDA has released information regarding tomorrow's panel meeting on PFO's and stroke. They say "docs" are very much as expected and the analyst expects the panel discussion to be positive for NMTI common, resulting in possible recommendations for a more achievable trial design. The analyst goes on to say that given the current environment, NMTI could become an acquisition target within the next 12-24 months by one of the larger medical device players such as BSX, JNJ, ABT, or MDT with a potential acquisition value of $23/share
    I thought this note was interesting...i figured investors may buy as a gamble into tomorrow's fda meeting..i will sell just under 15 though..